Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$336M |
| 2 |
Truist Financial
TFC
|
+$144M |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
+$103M |
| 4 |
Schwab US Aggregate Bond ETF
SCHZ
|
+$91.6M |
| 5 |
Home Depot
HD
|
+$90.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$323M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$136M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$56.6M |
| 4 |
GWR
Genesee & Wyoming Inc.
GWR
|
+$41.5M |
| 5 |
VSM
Versum Materials, Inc.
VSM
|
+$39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.04% |
| 2 | Financials | 14.33% |
| 3 | Healthcare | 12.99% |
| 4 | Industrials | 10.19% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
Clean Energy Fuels
CLNE
$386M
| $1.96M | ﹤0.01% |
837,133
+9,710
| +1% | +$20.6K |
|
2427
Central Garden & Pet Co
CENT
$2.79B
| $1.95M | ﹤0.01% |
78,584
-437
| -0.6% | -$10.4K |
|
2428
Melco Resorts & Entertainment
MLCO
$2.15B
| $1.95M | ﹤0.01% |
80,833
| – | – |
|
2429
Omega Flex
OFLX
$307M
| $1.95M | ﹤0.01% |
18,158
+408
| +2% | +$39.8K |
|
|
ACH
2430
Accendra Health
ACH
$96.1M
| $1.94M | ﹤0.01% |
374,943
+9,139
| +2% | +$58.7K |
|
2431
Arcus Biosciences
RCUS
$3.71B
| $1.94M | ﹤0.01% |
191,763
+2,078
| +1% | +$17.5K |
|
2432
Metallus
MTUS
$893M
| $1.93M | ﹤0.01% |
245,450
+6,701
| +3% | +$42K |
|
2433
Lifecore Biomedical
LFCR
$184M
| $1.92M | ﹤0.01% |
169,865
+5,863
| +4% | +$62.4K |
|
2434
Relmada Therapeutics
RLMD
$502M
| $1.92M | ﹤0.01% |
+49,187
| New | +$1.49M |
|
2435
Franklin Covey
FC
$232M
| $1.91M | ﹤0.01% |
59,216
+656
| +1% | +$23.8K |
|
2436
Arlo Technologies
ARLO
$1.53B
| $1.9M | ﹤0.01% |
450,356
+43,355
| +11% | +$149K |
|
|
TAST
2437
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $1.89M | ﹤0.01% |
268,539
+23,361
| +10% | +$171K |
|
2438
Park Aerospace
PKE
$826M
| $1.87M | ﹤0.01% |
114,999
+1,371
| +1% | +$22.7K |
|
|
BVH
2439
DELISTED
Bluegreen Vacations Holding Corporation
BVH
| $1.87M | ﹤0.01% |
78,461
+885
| +1% | +$20.4K |
|
2440
The RealReal
REAL
$1.41B
| $1.87M | ﹤0.01% |
99,253
+1,256
| +1% | +$24K |
|
2441
Forestar Group
FOR
$1.48B
| $1.87M | ﹤0.01% |
89,570
+28,117
| +46% | +$549K |
|
2442
Greif Class B
GEF.B
$4.22B
| $1.86M | ﹤0.01% |
36,022
+819
| +2% | +$40.6K |
|
2443
Inovio Pharmaceuticals
INO
$78.2M
| $1.86M | ﹤0.01% |
47,039
+53
| +0.1% | +$1.59K |
|
|
TLRD
2444
DELISTED
Tailored Brands, Inc.
TLRD
| $1.86M | ﹤0.01% |
448,755
-316,482
| -41% | -$1.49M |
|
|
CNST
2445
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $1.83M | ﹤0.01% |
38,914
+6,602
| +20% | +$191K |
|
2446
Bridgewater Bancshares
BWB
$608M
| $1.82M | ﹤0.01% |
132,362
+1,532
| +1% | +$19.4K |
|
2447
Limoneira
LMNR
$253M
| $1.82M | ﹤0.01% |
94,718
+1,352
| +1% | +$25.8K |
|
2448
Greenlight Captial
GLRE
$504M
| $1.82M | ﹤0.01% |
179,636
+2,023
| +1% | +$20.9K |
|
2449
KRONOS Worldwide
KRO
$915M
| $1.79M | ﹤0.01% |
133,606
+3,610
| +3% | +$47.3K |
|
|
VLRS
2450
Controladora Vuela Compania de Aviacion
VLRS
$900M
| $1.78M | ﹤0.01% |
170,476
+29,750
| +21% | +$317K |
|
Similar funds
Charles Schwab's Q4 2019 Portfolio in Review
As of Q4 2019, Charles Schwab held 3,227 positions worth $186B, up 9.8% from $169B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 3%. Charles Schwab opened 50 new positions and exited 48, leaving the 3,227-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2019 buy was Apollo Global Management: 821,197 shares worth $39.2M.
- Charles Schwab added most to Bristol-Myers Squibb in Q4 2019, an estimated $336M increase.
- Charles Schwab's biggest Q4 2019 reduction was Bank of America, cutting an estimated $34M.
- Charles Schwab fully exited Celgene Corp in Q4 2019, selling an estimated $323M.
- Charles Schwab's ten largest holdings make up 16% of its $186B portfolio in Q4 2019.
- Charles Schwab opened 50 new positions and closed 48 in Q4 2019.
- Charles Schwab's portfolio value rose 9.8% quarter-over-quarter to $186B.
Based on Charles Schwab's 13F filing for Q4 2019, filed 7 Feb 2020.